
Mark Hersee
Partner, Private Equity, Co-head of Healthcare
Biogaran, a leader in the generic market in France and an active contributor to cost savings in the French healthcare system, was founded over 25 years ago. Over the years, the company has established itself as a key player in the pharmaceutical industry. Today, Biogaran offers treatments across the full spectrum of therapeutic areas — from everyday conditions to the most serious diseases — and supplies a wide range of medicines, including antibiotics, antidiabetics, and anticancer drugs.

Partner, Private Equity, Co-head of Healthcare

Partner, Private Equity, Co-head of Services

Principal, Private Equity

Principal, Private Equity

Associate, Private Equity

BC Partners, a leading European investment firm, and Bpifrance, the French public investment bank, today announce the completion of the…

BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
At BC, we provide our portfolio companies with the access and expertise to scale into leading global businesses. We are a partner for growth.